DA-0218 structure
|
Common Name | DA-0218 | ||
---|---|---|---|---|
CAS Number | 1081317-31-8 | Molecular Weight | 543.711 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C36H37N3O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of DA-0218DA-0218 (DA0218) is a novel potent, selective Nav1.7 inhibitor, inhibits sodium currents in Nav1.7-expressing human embryonic kidney 293 cells with IC50 of 0.74 uM.DA-0218 has no effect on sodium currents in Nav1.5-transfected human embryonic kidney 293 cells in patch-clamp experiments.DA-0218 shows analgesic activity predominantly in phase II in formalin-induced inflammatory pain mouse model.DA-0218 produced acute reduction in paclitaxel-induced mechanical allodynia, and inhibited histamine-induced acute itch and lymphoma-induced chronic itch. |
Name | DA-0218 |
---|
Description | DA-0218 (DA0218) is a novel potent, selective Nav1.7 inhibitor, inhibits sodium currents in Nav1.7-expressing human embryonic kidney 293 cells with IC50 of 0.74 uM.DA-0218 has no effect on sodium currents in Nav1.5-transfected human embryonic kidney 293 cells in patch-clamp experiments.DA-0218 shows analgesic activity predominantly in phase II in formalin-induced inflammatory pain mouse model.DA-0218 produced acute reduction in paclitaxel-induced mechanical allodynia, and inhibited histamine-induced acute itch and lymphoma-induced chronic itch. |
---|---|
References | 1. Sharat Chandra, et al. Anesthesiology. 2020 Sep;133(3):611-627. |
Molecular Formula | C36H37N3O2 |
---|---|
Molecular Weight | 543.711 |